Novartis, Novartis Oncology Research, Oncology Drug Development, Cancer, Cancer Research, Innovative Medicines, Disease Patients, Treat Disease Patients; Novartis Oncology is driven by one vision: to transform the way patients live with cancer and related diseases ...

Contract Research; Tumor Markers; tissue image analysis provider for the pharma industry, specializing in quantitative tissue interpretation for immuno oncology drug development ...

Saladax develops novel blood tests to increase the impact of personalized medicine in psychiatry and oncology. the MyCare Psychiatry line provides antipsychotic drug levels for greater insight into patient adherence and possible treatment failures. Saladax believes that truly personalized medicine can only exist when the right drug is taken at the right dose. Saladax believes that truly personalized medicine can ...

Epistem's contract research services support the drug discovery and development pipeline, focussing in oncology, GI toxicity, mucositis, inflammation and skin ...

We share your passion for science. Promega develops tools that span oncology research to manipulate DNA & RNA, interrogate disease targets, screen small molecules & assay biologic drug candidates (including QC lot release). Toxicity mechanisms, epigenetics, kinases, PPI, target engagement, energy metabolism, inflammation, immuno oncology, sample prep liquid biopsy & FFPE. Let’s collaborate ...

Contract Research; MI Bioresearch is your premier preclinical oncology partner, leveraging focused scientific expertise and the industry’s widest breadth of tools to interrogate pharmacology in human and syngeneic tumor models. We provide you with decision driving data so you can confidently advance your potentially life changing drug candidate. One Focus. One Purpose. Oncology Research ...

HalioDx provides oncologists with first in class immuno oncology diagnostic products and services like Immunoscore Colon to guide therapeutic decision for existing agents or new immuno therapeutics. HalioDx has also a pipeline of unique and proprietary assays like Halioseek or Immunosign dedicated to guide immuno oncology drug development and stratify responder patients as Companion Diagnostics ...

DAVA Oncology was founded in 2007 with a mission to facilitate successful drug development. During our quest, we have created innovative solutions and services that accelerate the clinical development process ...

Contract Research; Tumor Markers; OcellO offers in vitro drug discovery and development services in oncology and immuno oncology. Our human 3D tissue culture models utilise PDX tumors, autologous normal and tumor organoids, primary tumor cells and their co culture with immune cells. Treatment effects are quantified using OcellO's unique high throughput, high content 3D imaging platform ...